Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Atherosclerosis ; 156(1): 91-101, 2001 May.
Article in English | MEDLINE | ID: mdl-11369001

ABSTRACT

Lipoprotein lipase (LPL) in the arterial wall has been proposed to enhance the retention of apoB-containing lipoproteins, an early event in atherosclerosis. As the neointima is considered the primary site of lipid accumulation in atherogenesis, the arterial expression and location of LPL was investigated in distinct experimental models of neointimal formation in normolipidemic rabbits and rats. Neointima elicited by balloon aortic denudation or raised beneath an anatomically intact endothelial layer by placing a silastic collar around the common carotid artery, both showed a striking LPL immunostaining that mostly co-localized with neointimal smooth muscle cells. Besides, increased LPL protein and mRNA in deendothelialized aortas was demonstrated by Western and Northern blot analysis, respectively, suggesting an enhanced expression of LPL in injured arteries. It was concluded that LPL is increased in neointima developed in either denuded vessels or arteries with a preserved endothelium, a finding which suggests that LPL abundance may be an attribute of the neointima, whatever the stimulus that promotes its formation. On the basis of former evidence concerning the role of LPL in lipid retention, this study provides a possible explanation for the injury-induced vessel susceptibility to atherosclerosis, and the particular proneness of the neointimal layer to lipid accretion.


Subject(s)
Aorta/enzymology , Arteriosclerosis/etiology , Carotid Arteries/enzymology , Lipoprotein Lipase/metabolism , Tunica Intima/enzymology , Animals , Aorta/metabolism , Aorta, Thoracic/pathology , Carotid Arteries/metabolism , Carotid Arteries/pathology , Endothelium, Vascular/physiology , Lipoprotein Lipase/genetics , Male , RNA, Messenger/metabolism , Rabbits , Rats , Rats, Wistar , Risk Factors
2.
Cogn Affect Behav Neurosci ; 1(4): 388-93, 2001 Dec.
Article in English | MEDLINE | ID: mdl-12467090

ABSTRACT

In a recent study (Tafet, Toister-Achituv, & Shinitzky, 2001), we demonstrated that cortisol induces an increase in the expression of the gene coding for the serotonin transporter, associated with a subsequent elevation in the uptake of serotonin. This stimulatory effect, produced upon incubation with cortisol in vitro, was observed in peripheral blood lymphocytes from normal subjects. In the present work we investigated the cortisol-induced increase in serotonin uptake in lymphocytes from hypercortisolemic patients, including subjects with major depressive disorder (n = 8), and subjects with generalized anxiety disorder (n = 12), in comparison with a control group of normal healthy subjects (n = 8). A significant increase in serotonin uptake (+37% + 14, M + SD) was observed in the control group, whereas neither the generalized anxiety disorder nor the major depression group exhibited changes in serotonin uptake upon incubation with cortisol. It is likely that under chronic stress or depression, the capacity for increase in serotonin transporter has reached its limit due to the chronically elevated blood cortisol level. The physiological and diagnostic implications of this observation are discussed.


Subject(s)
Carrier Proteins/physiology , Depressive Disorder, Major/physiopathology , Hydrocortisone/physiology , Membrane Glycoproteins/physiology , Membrane Transport Proteins , Nerve Tissue Proteins , Serotonin/blood , Stress, Psychological/physiopathology , Adult , Arousal/physiology , Carrier Proteins/genetics , Chronic Disease , Circadian Rhythm/physiology , Female , Gene Expression/physiology , Humans , Hypothalamo-Hypophyseal System/physiopathology , Lymphocytes/metabolism , Male , Membrane Glycoproteins/genetics , Middle Aged , Pituitary-Adrenal System/physiopathology , Serotonin Plasma Membrane Transport Proteins
SELECTION OF CITATIONS
SEARCH DETAIL